>

PARABOLIC DRUGS (India) Performance

<div class='circular--portrait' style='background:#2A0CD0;color: white;font-size:4em;padding-top: 25px;;'>PA</div>
The corporation holds Beta of 0.0 which implies the returns on MARKET and PARABOLIC DRUGS are completely uncorrelated. Although it is extremely important to respect PARABOLIC DRUGS LTD current trending patterns, it is better to be realistic regarding the information on equity existing price patterns. The approach into forecasting future performance of any stock is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators. By inspecting PARABOLIC DRUGS LTD technical indicators you can now evaluate if the expected return of 0.0% will be sustainable into the future. PARABOLIC DRUGS LTD currently holds a risk of 0.0%. Please check PARABOLIC DRUGS LTD Treynor Ratio, Downside Variance, Kurtosis, as well as the relationship between Value At Risk and Expected Short fall to decide if PARABOLIC DRUGS LTD will be following its historical price patterns.
00

Risk-Adjusted Performance

Over the last 30 days PARABOLIC DRUGS LTD has generated negative risk-adjusted returns adding no value to investors with long positions. In defiance of relatively invariable forward-looking signals, PARABOLIC DRUGS is not utilizing all of its potentials. The current stock price agitation, may contribute to short term losses for the management.
Quick Ratio0.08
Fifty Two Week Low0.6500
Fifty Two Week High4.2000

PARABOLIC DRUGS LTD Relative Risk vs. Return Landscape

If you would invest (100.00)  in PARABOLIC DRUGS LTD on January 24, 2020 and sell it today you would earn a total of  100.00  from holding PARABOLIC DRUGS LTD or generate -100.0% return on investment over 30 days. PARABOLIC DRUGS LTD is generating negative expected returns and assumes 0.0% volatility on return distribution over the 30 days horizon. Simply put, 0% of equities are less volatile than PARABOLIC DRUGS and 99% of equity instruments are likely to generate higher returns than the company over the next 30 trading days.
 Daily Expected Return (%) 
    
  Risk (%) 

PARABOLIC DRUGS Market Risk Analysis

Sharpe Ratio = 0.0
Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small Returns
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
PARABDRUGS
Based on monthly moving average PARABOLIC DRUGS is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of PARABOLIC DRUGS by adding it to a well-diversified portfolio.

PARABOLIC DRUGS Alerts

Equity Alerts and Improvement Suggestions

PARABOLIC DRUGS LTD is not yet fully synchronised with the market data
PARABOLIC DRUGS LTD has some characteristics of a very speculative penny stock
PARABOLIC DRUGS LTD has high likelihood to experience some financial distress in the next 2 years
PARABOLIC DRUGS LTD has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
The company has accumulated 4.21 B in total debt with debt to equity ratio (D/E) of 265.1 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. PARABOLIC DRUGS LTD has Current Ratio of 0.19 indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.
The entity reported revenue of 731.57 M. Net Loss for the year was (575.48 M) with profit before overhead, payroll, taxes, and interest of 92.9 M.
Check out Your Equity Center. Please also try Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Company logos by clearbit